GE HealthCare – Growth Acceleration Meets P/E of 14 – I Am Considering a Long Position!

GE HealthCare's order backlog reached $23.7 billion, providing visibility until 2028.

Flyrcado addresses a US market with around 6 million heart examinations annually. By the end of 2028, an annualized revenue run rate of $500 million is expected.

A. Zehetner 10/29/2026 at 11 AM

Reading Time: 2 minutes

The medical technology sector is demonstrating strong leadership during this earnings season. Since October 1, the sector ETF IHI has gained 7.9%, while the Nasdaq-100 ETF QQQ has lost 2.2%. I am currently considering establishing a long position in GE HealthCare (GEHC) . The moderate valuation with an estimated P/E ratio of around 14 and several growth drivers support this decision. GE HealthCare provides hospitals with CT, MRI, and ultrasound machines as well as AI software and diagnostic agents. New AI-powered premium devices are expected to...

Read this article now with a free account.

Your benefits:

Every month, you can read 5 articles from the premium section for free.
Monthly 2 trial issues of the Trader newspaper for free.
Create a personal watchlist with an overview of news about your stock.

Trader Times
Free account Here we go!

Already registered? Log In